Skip to content
OpenCapital
Get started

BioCryst Pharmaceuticals BCRX Taxes withheld on stock-based awards included in accrued expenses

Taxes withheld on stock-based awards included in accrued expenses at other companies

OUTFRONT Media logo
OUTFRONT MediaOUT
$2.8M+7.7%
RXO logo
RXORXO
$1M0.0%
Grindr logo
GrindrGRND
$0-100%
Tradeweb Markets Inc. logo
Tradeweb Markets Inc.TW
$1.32M-17.3%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
$3.94M+345%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$943.25K—

Other financials

Income statement

See full
Revenue$156.4M+7.5%
Gross profit$151.0M+7.1%
Operating income-$701.6M-3,405%
Net income-$721.8M-2,255,763%
EPS (diluted)-$2.98—

Balance sheet

See full
Cash & equivalents$173.4M+62.2%
Total debt$411.8M+24.7%
Total equity-$553.8M-22.6%
Total assets$465.1M-3.1%

Cash flow

See full
Operating cash flow-$61.8M-125%
CapEx$403.0K+182%
Free cash flow-$62.2M-125%

Valuation

See full
Market cap$2.37B+52.3%
Enterprise value$2.6B+46.7%
P/S2.7×-0.4×

Profitability

See full
Gross margin97.8%+0.8pp
Operating margin-43.1%-49.7pp
Net margin-51.7%-69.7pp
FCF margin35%—

Returns & leverage

See full
Return on equity-882.8%—
Debt / equity0.1×—
Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept bcrx:WithholdingTaxesAccrued.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's taxes withheld on stock-based awards included in accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioCryst Pharmaceuticals's taxes withheld on stock-based awards included in accrued expenses?
BioCryst Pharmaceuticals (BCRX) reported taxes withheld on stock-based awards included in accrued expenses of $3.17M in Q1 2026.
How has BioCryst Pharmaceuticals's taxes withheld on stock-based awards included in accrued expenses changed year-over-year?
BioCryst Pharmaceuticals's taxes withheld on stock-based awards included in accrued expenses increased by 1049.3% year-over-year, from $276K to $3.17M.
What is the long-term trend for BioCryst Pharmaceuticals's taxes withheld on stock-based awards included in accrued expenses?
Over 2 years (2021 to 2023), BioCryst Pharmaceuticals's taxes withheld on stock-based awards included in accrued expenses has grown at a 108.6% compound annual growth rate (CAGR), from $984K to $4.28M.
What does taxes withheld on stock-based awards included in accrued expenses mean?
This represents the portion of tax obligations related to employee stock-based compensation that the company withholds and settles on behalf of the employees. It captures the cash impact of tax liabilities arising from the vesting or exercise of equity awards that are recorded within accrued expenses. This metric is useful for understanding the cash flow implications of equity-based incentive programs and their associated tax reporting requirements.